From lab to patient: journey of a medicine

Published by EMA

Centralised Procedure Committee for Orphan Medicinal Products EMA Drug Development EU Marketing Authorisation Road Map Marketing Authorisation National Procedure Regulatory Affairs Scientific Advice

Follow the journey of a medicine for human use assessed by EMA in this interactive timeline. It explains all stages from initial research to patient access, including how EMA supports medicine development, assesses the benefits and risks and monitors the Safety of medicines.

View this resource Bookmark this resource

From laboratory to patient: the journey of a medicine assessed by EMA

Published by EMA

Committee for Orphan Medicinal Products EMA Drug Development EU Marketing Authorisation Road Map Marketing Authorisation Regulatory Affairs Scientific Advice

This booklet covers medicines for human use that are authorised via EMA through the EU centralised procedure.

View this resource Bookmark this resource

The Innovation Management Toolbox was originally developed through funding from the EJP RD project, which received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 825575. The continued development and maintenance of the Toolbox are now supported by the ERDERA partnership, funded under the European Union’s Horizon Europe Research & Innovation programme, grant agreement No. 101156595.

IMT Feedback

Did the IMT help you in finding the resource you needed?

From lab to patient: journey of a medicine

From laboratory to patient: the journey of a medicine assessed by EMA